Company: CMND
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001213900-25-117534
Chunk: 28

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 28
---
 prices. If any underwriters, agents or dealers are involved in the sale of any of these securities, the applicable prospectus supplement will set forth the names of the underwriter, agent or dealer and any applicable fees, commissions or discounts.

Our Common Shares are currently traded on the Nasdaq Capital Market, or Nasdaq, under the symbol “CMND.” On December 21, 2023, the last reported sale price of our Common Shares on the Nasdaq was $3.12.

Our Common Shares also trade on the Canadian Securities Exchange, or CSE under the symbol “CMND” and on the Frankfurt Stock Exchange, or FSE, under the symbol “CWY”. On December 21, 2023, the last reported sales price of our Common Shares on CSE and FSE was CAD$4.07 (approximately $3.07) and EUR 2.63 (approximately $2.90) per share, respectively.

The aggregate market value of our outstanding voting and non-voting common equity held by non-affiliates on December 21, 2023, as calculated in accordance with General Instruction I.B.5. of Form F-3, was approximately $7.66 million. We have not offered any securities pursuant to General Instruction I.B.5 of Form F-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus.

Investing in our securities involves a high degree of risk. Please carefully consider the risks discussed in this prospectus under “Risk Factors” beginning on page 6 and the “Risk Factors” in “Item 3: Key Information- Risk Factors” of our most recent Annual Report on Form 20-F incorporated by reference in this prospectus and in any applicable prospectus supplement for a discussion of the factors you should consider carefully before deciding to purchase these securities.

Neither the Securities and Exchange Commission (or the SEC) nor the Canadian Securities Exchange, nor any state or other foreign securities commission has approved nor disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is, 2023

TABLE OF CONTENTS</div>

| About                             
 this Prospectus                   |     |  1 |
| Our                               
 Business                          |     |  4 |
| Risk                              
 Factors                           |     |  6 |
| Offer                             
 Statistics and Expected Timetable |     |  7 |
| Forward